Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats.
Starckx S, Batheja A, Verheyen GR, Jonghe SD, Steemans K, Dijck BV, Singer M, Bogdan N, Snoeys J, Vinken P, Sasaki JC, Gompel JV, Guzzie-Peck P, Lampo A, Lammens L. Starckx S, et al. Among authors: lammens l. Toxicol Pathol. 2013 Jul;41(5):795-804. doi: 10.1177/0192623312464436. Epub 2012 Nov 9. Toxicol Pathol. 2013. PMID: 23143187
Unexpected nasal changes in rats related to reflux after gavage dosing.
Damsch S, Eichenbaum G, Looszova A, Lammens L, Feyen B, Van den Bulck K, Knight E, Kelley M, Tonelli A. Damsch S, et al. Among authors: lammens l. Toxicol Pathol. 2011 Feb;39(2):337-47. doi: 10.1177/0192623310388430. Epub 2010 Dec 14. Toxicol Pathol. 2011. PMID: 21422260
Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
Mesens N, Desmidt M, Verheyen GR, Starckx S, Damsch S, De Vries R, Verhemeldonck M, Van Gompel J, Lampo A, Lammens L. Mesens N, et al. Among authors: lammens l. Toxicol Pathol. 2012 Apr;40(3):491-503. doi: 10.1177/0192623311432290. Epub 2012 Jan 30. Toxicol Pathol. 2012. PMID: 22291062
Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk/benefit to patients.
Lachau-Durand S, Lammens L, van der Leede BJ, Van Gompel J, Bailey G, Engelen M, Lampo A. Lachau-Durand S, et al. Among authors: lammens l. PLoS Negl Trop Dis. 2019 Jan 16;13(1):e0007026. doi: 10.1371/journal.pntd.0007026. eCollection 2019 Jan. PLoS Negl Trop Dis. 2019. PMID: 30650076 Free PMC article.
26 results